Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2004-9-14
pubmed:abstractText
S100 proteins belong to the EF-hand Ca2+-binding protein family and are involved in the regulation of a variety of cellular processes. Individual S100 proteins are expressed in cell- and tissue-specific manners, and functional deterioration of S100 proteins leads to a number of human diseases, including cancer. We previously demonstrated that S100C/A11 was translocated to nuclei and inhibited DNA synthesis in human keratinocytes when exposed to high Ca2+. In the present study we examined the effects of synthetic partial peptides of S100C/A11 on human carcinoma cell lines. Only an N-terminal peptide with 19 amino acid residues (MAK19) showed cytotoxicity to the cell lines in dose- and time-dependent manners when introduced into cells by flanking the HIV-TAT protein transduction domain (TAT-MAK19). Pulse field electrophoresis revealed that DNA of the treated cells was partially degradated. Annexin V, a marker of cellular apoptosis, was detected in the cells treated with TAT-MAK19 by immunostaining and flow cytometry. The induction of apoptotic cell death was apparently independent of p53, p21WAF1/CIP1, and caspase activity, but treatment with TAT-MAK19 resulted in partial translocation of apoptosis-inducing factor (AIF) from the cytoplasm to nuclei. These results indicate that MAK19 induces apoptosis in human cell lines and may therefore lead to the establishment of a new molecular target for the treatment of human cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0946-2716
pubmed:author
pubmed:issnType
Print
pubmed:volume
82
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
612-20
pubmed:dateRevised
2011-7-8
pubmed:meshHeading
pubmed-meshheading:15241500-Amino Acid Sequence, pubmed-meshheading:15241500-Apoptosis, pubmed-meshheading:15241500-Carcinoma, pubmed-meshheading:15241500-Carcinoma, Squamous Cell, pubmed-meshheading:15241500-Cell Cycle Proteins, pubmed-meshheading:15241500-Cell Line, Transformed, pubmed-meshheading:15241500-Cell Line, Tumor, pubmed-meshheading:15241500-Cells, Cultured, pubmed-meshheading:15241500-Cyclin-Dependent Kinase Inhibitor p21, pubmed-meshheading:15241500-DNA Replication, pubmed-meshheading:15241500-Drug Design, pubmed-meshheading:15241500-Gene Expression Regulation, pubmed-meshheading:15241500-Gene Products, tat, pubmed-meshheading:15241500-Humans, pubmed-meshheading:15241500-Melanoma, pubmed-meshheading:15241500-Molecular Sequence Data, pubmed-meshheading:15241500-Peptide Fragments, pubmed-meshheading:15241500-Protein Structure, Tertiary, pubmed-meshheading:15241500-Protein Transport, pubmed-meshheading:15241500-S100 Proteins
pubmed:year
2004
pubmed:articleTitle
Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death.
pubmed:affiliation
Department of Dermatology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikatachou, 700-8558, Okayama, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't